中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2014年
8期
1629-1631
,共3页
陈钢%刘相燕%王洲%刘曦
陳鋼%劉相燕%王洲%劉晞
진강%류상연%왕주%류희
肺癌%肿瘤复发%CXC趋化因子受体4
肺癌%腫瘤複髮%CXC趨化因子受體4
폐암%종류복발%CXC추화인자수체4
Lung carcinoma%Tumor recurrence%CXC chemokine receptor-4
目的 探讨CXC趋化因子受体4(CXCR4)的表达与N2期肺癌术后早期复发的关系.方法 采用逆转录-聚合酶链反应(RT-PCR)方法检测84例手术治疗的N2期非小细胞肺癌患者的癌组织中CXCR4mRNA的表达,应用x2检验比较CXCR4表达的差异.随访患者并分析N2期肺癌术后早期复发模式.应用Logistic回归分析判定N2期肺癌术后早期复发的独立相关因素.结果 CXCR4mRNA在60例(71.4%)肺癌组织中表达,与年龄、性别、肿瘤类型、分化程度、T分期均无相关(P>0.05).术后1年内39例(46.4%)患者肿瘤复发,以转移性复发为主(74.4%).CXCR4表达阳性患者复发率明显高于阴性患者(P<0.05).术后1年总体生存率为65.48%,CXCR4表达阳性患者无复发生存期显著低于阴性患者(P<0.05).Logistic回归分析结果显示,癌组织中CXCR4表达、未行术后辅助治疗是N2期肺癌术后早期复发的独立相关因素.结论 CXCR4在N2期肺癌组织中高表达,与术后早期复发密切相关;N2期肺癌患者术后早期复发模式主要为转移性复发.
目的 探討CXC趨化因子受體4(CXCR4)的錶達與N2期肺癌術後早期複髮的關繫.方法 採用逆轉錄-聚閤酶鏈反應(RT-PCR)方法檢測84例手術治療的N2期非小細胞肺癌患者的癌組織中CXCR4mRNA的錶達,應用x2檢驗比較CXCR4錶達的差異.隨訪患者併分析N2期肺癌術後早期複髮模式.應用Logistic迴歸分析判定N2期肺癌術後早期複髮的獨立相關因素.結果 CXCR4mRNA在60例(71.4%)肺癌組織中錶達,與年齡、性彆、腫瘤類型、分化程度、T分期均無相關(P>0.05).術後1年內39例(46.4%)患者腫瘤複髮,以轉移性複髮為主(74.4%).CXCR4錶達暘性患者複髮率明顯高于陰性患者(P<0.05).術後1年總體生存率為65.48%,CXCR4錶達暘性患者無複髮生存期顯著低于陰性患者(P<0.05).Logistic迴歸分析結果顯示,癌組織中CXCR4錶達、未行術後輔助治療是N2期肺癌術後早期複髮的獨立相關因素.結論 CXCR4在N2期肺癌組織中高錶達,與術後早期複髮密切相關;N2期肺癌患者術後早期複髮模式主要為轉移性複髮.
목적 탐토CXC추화인자수체4(CXCR4)적표체여N2기폐암술후조기복발적관계.방법 채용역전록-취합매련반응(RT-PCR)방법검측84례수술치료적N2기비소세포폐암환자적암조직중CXCR4mRNA적표체,응용x2검험비교CXCR4표체적차이.수방환자병분석N2기폐암술후조기복발모식.응용Logistic회귀분석판정N2기폐암술후조기복발적독립상관인소.결과 CXCR4mRNA재60례(71.4%)폐암조직중표체,여년령、성별、종류류형、분화정도、T분기균무상관(P>0.05).술후1년내39례(46.4%)환자종류복발,이전이성복발위주(74.4%).CXCR4표체양성환자복발솔명현고우음성환자(P<0.05).술후1년총체생존솔위65.48%,CXCR4표체양성환자무복발생존기현저저우음성환자(P<0.05).Logistic회귀분석결과현시,암조직중CXCR4표체、미행술후보조치료시N2기폐암술후조기복발적독립상관인소.결론 CXCR4재N2기폐암조직중고표체,여술후조기복발밀절상관;N2기폐암환자술후조기복발모식주요위전이성복발.
Objective To investigate the relationship between CXC chemokine receptor-4 (CXCR4) expression and postoperative early recurrence in patients with N2 lung cancer.Methods The cancer tissues from 84 patients with N2 lung cancer were examined by reverse transcription-polymerase chain reaction (RT-PCR) for detection of the CXCR4 mRNA expression.The difference was compared by x2 test.All patients were evaluated within 1 year after surgery to monitor tumor recurrence.Logistic regression analysis was performed to determine the risk factors of early recurrence.Results CXCR4 expression was observed in 60 cases of (71.4%) lung cancer.Early recurrence occurred in 39 patients (46.4%),and the main pattern was hematogenous.The recurrence rate in patients positive for CXCR4 expression was significantly higher than in those negative for the CXCR4 expression (P < 0.05).The overall 1-year survival rate was 65.48%,and recurrence-free survival in patients positive for the CXCR4 expression was significantly shorter than that in those negative for the CXCR4 expression (P < 0.05).Logistic regression analysis revealed that positive CXCR4 expression [odds ratio (OR) =5.048,P < 0.01] and no postoperative adjuvant therapy (OR =3.806,P < 0.05) were independent risk factors of postoperative early recurrence.Conclusion CXCR4 expression was high in N2 lung cancer,with significant correlation to postoperative early recurrence.About one half of the patients would develop recurrence within 1 year after surgery,with mainly hematogenous metastasis.